Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Plasma Pentraxin 3 Concentration With Angiographic and Clinical Outcomes in STEMI Treated by Primary Angioplasty

NCT03894176 is registered in ClinicalTrials.gov with Indonesian Cardiovascular Research Center as lead sponsor.

NCT NCT03894176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Plasma Pentraxin 3 Concentration With Angiographic and Clinical Outcomes in STEMI Treated by Primary Angioplasty
Lead sponsor
Indonesian Cardiovascular Research Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
September 2, 2018
Enrollment
335 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary; ischemic, stemi